NATALIE WISNESKI: Open Payments
NPI 1265843916 · BENSALEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 25 payments from 8 companies in 2025. Trend: 2023 $515 · 2024 $551 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| PFIZER INC. | 7 | $129 |
| Amgen Inc. | 4 | $76 |
| Lilly USA, LLC | 3 | $50 |
| Exact Sciences Corporation | 2 | $39 |
| Novo Nordisk Inc | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: FARXIGA, PAXLOVID, OTEZLA, ELIQUIS, MOUNJARO, Cologuard Collection Kit, AIRSUPRA, REPATHA.
Industry payments across PA — which companies pay providers there.
